← Back to Search

Contact Lenses

LID022821, then AOHP for Refractive Errors

N/A
Waitlist Available
Research Sponsored by Alcon Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 1, each wear period. a wear period was approximately 14 days.
Awards & highlights

Study Summary

The purpose of this study is to assess the clinical performance of two reusable silicone hydrogel contact lenses when worn on a daily wear basis.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 1, each wear period. a wear period was approximately 14 days.
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 1, each wear period. a wear period was approximately 14 days. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Visual Acuity With Study Lenses at Week 1 Follow-Up

Trial Design

2Treatment groups
Experimental Treatment
Group I: LID022821, then AOHPExperimental Treatment3 Interventions
Serafilcon A contact lenses worn during Period 1, with senofilcon A contact lenses worn during Period 2, as randomized. Each study lens type will be worn bilaterally (in both eyes) at least 10 hours per day for approximately 14 days. CLEAR CARE will be used for daily cleaning and disinfection. The serafilcon A contact lenses will be replaced with a fresh pair at the Week 1 follow-up visit.
Group II: AOHP, then LID022821Experimental Treatment3 Interventions
Senofilcon A contact lenses worn during Period 1, with serafilcon A contact lenses worn during Period 2, as randomized. Each study lens type will be worn bilaterally (in both eyes) at least 10 hours per day for approximately 14 days. CLEAR CARE will be used for daily cleaning and disinfection. The serafilcon A contact lenses will be replaced with a fresh pair at the Week 1 follow-up visit.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Serafilcon A contact lenses
2022
N/A
~260
Senofilcon A contact lenses
2022
N/A
~1790
CLEAR CARE
2022
N/A
~1570

Find a Location

Who is running the clinical trial?

Alcon ResearchLead Sponsor
704 Previous Clinical Trials
124,443 Total Patients Enrolled
101 Trials studying Refractive Errors
11,816 Patients Enrolled for Refractive Errors
Clinical Trial Lead, CDMA Vision CareStudy DirectorAlcon Research, LLC
1 Previous Clinical Trials
76 Total Patients Enrolled
1 Trials studying Refractive Errors
76 Patients Enrolled for Refractive Errors

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Clinical Performance of Two Reusable Silicone Hydrogel Contact Lenses
2022. "Clinical Performance of Two Reusable Silicone Hydrogel Contact Lenses". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05431478.
~25 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top